LLMpediaThe first transparent, open encyclopedia generated by LLMs

OPAL reactor

Generated by GPT-5-mini
Note: This article was automatically generated by a large language model (LLM) from purely parametric knowledge (no retrieval). It may contain inaccuracies or hallucinations. This encyclopedia is part of a research project currently under review.
Article Genealogy
Parent: ANSTO Hop 4
Expansion Funnel Raw 45 → Dedup 0 → NER 0 → Enqueued 0
1. Extracted45
2. After dedup0 (None)
3. After NER0 ()
4. Enqueued0 ()
OPAL reactor
NameOPAL
LocationLucas Heights, New South Wales, Australia
CountryAustralia
OperatorAustralian Nuclear Science and Technology Organisation
StatusOperational
TypePool-type
Thermal capacity20 MW
Commissioned2006

OPAL reactor

Introduction

The OPAL reactor is a 20 megawatt research reactor located at Lucas Heights, New South Wales, operated by the Australian Nuclear Science and Technology Organisation and owned by the Commonwealth of Australia. It supports nuclear medicine, neutron scattering, isotope production, and materials research for institutions such as the University of Sydney, University of New South Wales, and international partners including the International Atomic Energy Agency. The facility is a cornerstone of Australian scientific infrastructure alongside institutions like the CSIRO and national facilities such as the Australian Synchrotron.

Design and Technical Specifications

OPAL is a light water cooled, light water moderated, and beryllium reflected pool-type research reactor based on technology developed in collaboration with international vendors and modeled after reactors such as the High Flux Reactor (FRM-II), the JEEP II reactor, and designs from Areva and INVAP. Core components include fuel assemblies supplied under oversight by the Nuclear Regulatory Commission (United States) equivalently interacting with Australian regulatory bodies. The reactor uses low-enriched uranium fuel compatible with non-proliferation efforts promoted by the Nuclear Non-Proliferation Treaty and supported by the Global Threat Reduction Initiative. Engineering subsystems reference cooling practices from projects at the Oak Ridge National Laboratory, instrumentation concepts employed at the Institut Laue-Langevin, and safety analyses akin to standards promulgated by the International Atomic Energy Agency.

Key technical specifications cover thermal power of 20 MW, beamports for neutron scattering similar to installations at the ISIS neutron source and the Institut Laue-Langevin, and a hot cell complex for radiochemical processing comparable to facilities at the National Research Council (Canada) and Argonne National Laboratory. Neutron flux and irradiation rigs support transmutation and activation experiments conducted by researchers affiliated with the Australian Nuclear Science and Technology Organisation and partner universities including Monash University, University of Melbourne, and University of Queensland.

Research and Applications

OPAL provides neutrons for techniques such as neutron diffraction and small-angle neutron scattering used by groups at the Australian Centre for Neutron Scattering, collaborative projects with the Commonwealth Scientific and Industrial Research Organisation, and materials studies relevant to the Australian Defence Force. Medical radioisotope production at OPAL supplies molybdenum-99 and other isotopes for hospitals including Royal Prince Alfred Hospital and nuclear medicine departments at the Peter MacCallum Cancer Centre. Industrial applications encompass neutron radiography for aerospace firms like Qantas suppliers and quality assurance programs for energy companies such as Origin Energy.

International collaborations involve researchers from the United States Department of Energy, the European Commission, and programs coordinated through the International Atomic Energy Agency. OPAL’s user program supports doctoral and postdoctoral projects for academics from institutions such as Australian National University and Griffith University.

Safety and Regulatory Framework

OPAL operates under regulation by the Australian Radiation Protection and Nuclear Safety Agency with licensing conditions reflecting guidance from the International Atomic Energy Agency and oversight practices comparable to those enforced by the Nuclear Regulatory Commission (United States). Emergency planning coordinates with New South Wales Police Force and NSW Health for public protection and incident response, while occupational health programs align with the Safe Work Australia model. Security arrangements reference standards advocated by the International Atomic Energy Agency and cooperation with intelligence agencies including the Australian Security Intelligence Organisation for threat assessment.

Environmental monitoring and waste management follow protocols similar to those at the Waste Isolation Pilot Plant and national frameworks for radioactive waste custody in Australia, with outputs tracked under national reporting to the Commonwealth Department of Industry, Science and Resources.

History and Development

OPAL was developed to replace the older HIFAR reactor and entered service in the mid-2000s following construction driven by national policy debates involving the Commonwealth of Australia and scientific stakeholders such as the Australian Academy of Science. Design, construction, and commissioning involved international suppliers and technical exchanges with organizations including INVAP and fabrication expertise reflecting global reactor procurement practices. Funding and policy oversight intersected with parliamentary debates and ministerial decisions in Canberra and were influenced by international events like agreements under the Nuclear Non-Proliferation Treaty framework.

The commissioning program included acceptance tests, benchmarking against international facilities such as the High Flux Reactor (FRM-II), and the establishment of a user program modeled on practices at the Institut Laue-Langevin and ISIS neutron source.

Incidents and Operational Challenges

Operational challenges have included equipment故障, maintenance outages, and supply-chain issues for reactor components and isotope production affected by international market dynamics and logistics comparable to disruptions experienced by facilities such as the NRU reactor and other research reactors worldwide. Safety reviews and periodic shutdowns have been managed under the regulatory framework of the Australian Radiation Protection and Nuclear Safety Agency and informed by incident investigations similar in process to those conducted by the International Atomic Energy Agency. Planned maintenance, aging management, and contingency planning continue to be priorities, coordinated with academic users including Macquarie University and research partners such as CSL Limited.

Category:Nuclear reactors in Australia